Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Journal of Virology|September 15, 2017
Vector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4+ and CD8+ T-Cell ResponsesUlrike Sauermann, Antonia Radaelli, Nicole Stolte-Leeb, et al.
Neuro-Oncology|June 12, 2016
Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brainNicole L Goerig, Benjamin Frey, Klaus Korn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2020
Early Mortality of Brain Cancer Patients and its Connection to Cytomegalovirus Reactivation During RadiochemotherapyNicole L Goerig, Benjamin Frey, Klaus Korn, et al.
Vaccines|February 26, 2022
Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected ParticipantsDavid Peterhoff, Sebastian Einhauser, Stephanie Beileke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2015
Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th CellsMichael Storcksdieck genannt Bonsmann, Thomas Niezold, Vladimir Temchura, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 20, 2020
Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2Dennis Lapuente, Clara Maier, Pascal Irrgang, et al.
Pharmaceutics|July 27, 2022
Design and Functional Characterization of HIV-1 Envelope Protein-Coupled T Helper LiposomesDominik Damm, Ehsan Suleiman, Hannah Theobald, et al.
Journal of Virology|June 20, 2024
Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate modelChristiane Stahl-Hennig, Antonia Sophia Peter, Arne Cordsmeier, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 5, 2023
Modulation of immune responses to liposomal vaccines by intrastructural helpDominik Damm, Ehsan Suleiman, Jannik T Wagner, et al.
Viruses|December 9, 2020
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In VitroFriedrich Hahn, Christina Wangen, Sigrun Häge, et al.
Pageof 10